ConductScience.org, home

Paper464567

Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study.

Washington JA and 4 others. Antimicrob Agents Chemother, 1979. Cited by 17 papers, by iCite.

Cite this record

ConductScience Library. Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study. Papers, record 464567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/464567

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interpretation of the disk diffusion susceptibility test for amikacin: report of a collaborative study.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Washington JA 2ndJ A
2Yu PKP K
3Gavan TLT L
4Schoenknecht FDF D
5Thornsberry CC

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmikacinMajor topic
KanamycinMajor topic
Bacteria
Methods
Microbial Sensitivity Tests

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115830470Resistance of Pseudomonas aeruginosa to gentamicin and related aminoglycoside antibiotics.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15830470PubMed
2101130Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/101130PubMed
3412464Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/412464PubMed
4415096Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.J Infect Dis1978https://conductscience.org/library/papers/415096PubMed
5415034Uniformity in sensitivity test media.J Antimicrob Chemother1978https://conductscience.org/library/papers/415034PubMed
6324279Significance of antimicrobial synergism for the outcome of gram negative sepsis.Am J Med Sci1977https://conductscience.org/library/papers/324279PubMed
7868901Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria.Am J Med1977https://conductscience.org/library/papers/868901PubMed
85325707Antibiotic susceptibility testing by a standardized single disk method.Am J Clin Pathol1966https://conductscience.org/library/papers/5325707PubMed
94372272Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.J Infect Dis1974https://conductscience.org/library/papers/4372272PubMed
104983355Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.J Clin Pathol1969https://conductscience.org/library/papers/4983355PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
7447420Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7447420PubMed
7352748Evaluation of a commercial microdilution system for quantitative susceptibility testing of aminoglycosides against multidrug-resistant, gram-negative bacilli.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/7352748PubMed
6816738
[Resistance of clinical isolates of some Enterobacteriaceae as well as Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus faecalis to chemotherapeutic agents. Results of an inter-regional cooperative study for the years 1980 and 1981].
Infection1982https://conductscience.org/library/papers/6816738PubMed
6787072Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.J Clin Microbiol1981https://conductscience.org/library/papers/6787072PubMed
6619294Proposed zone standards for interpretation of fortimicin A disk diffusion tests.J Clin Microbiol1983https://conductscience.org/library/papers/6619294PubMed
1748119Quality control in antimicrobial disk susceptibility testing: a Belgian multicenter study.Eur J Clin Microbiol Infect Dis1991https://conductscience.org/library/papers/1748119PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/464567

GET https://conductscience.org/api/papers/v1/464567/authors